Vertex Pharmaceuticals (VRTX) Free Cash Flow Growth (1y) (2010 - 2026)
Vertex Pharmaceuticals (VRTX) Free Cash Flow Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | - |
| 2 | Belite Bio | 55,234.00 Bn | 55,234.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,823.14 Bn | 17,823.14 Bn | - | 60.84% |
| 4 | Legend Biotech | 3,624.50 Bn | 3,624.21 Bn | 242.10 Mn | 88.70% |
| 5 | Akari Therapeutics | 1,745.73 Bn | 1,745.73 Bn | - | -15.72% |
| 6 | Evaxion A | 1,540.85 Bn | 1,540.84 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.57 Bn | 105.33 Bn | 2.59 Bn | 66.37% |
| 9 | Abivax | 93.46 Bn | 93.46 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.55 Bn | 54.80 Bn | 3.31 Bn | 3.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 66.37% |
| Dec 31, 2025 | -29.15% |
| Sep 30, 2025 | -12.48% |
| Jun 30, 2025 | 124.26% |
| Mar 31, 2025 | -37.15% |
| Dec 31, 2024 | 178.75% |
| Sep 30, 2024 | 6.05% |
| Jun 30, 2024 | -455.66% |
| Mar 31, 2024 | 44.35% |
| Dec 31, 2023 | -83.11% |
| Sep 30, 2023 | 36.23% |
| Jun 30, 2023 | -1.08% |
| Mar 31, 2023 | -3.90% |
| Dec 31, 2022 | 11.96% |
| Sep 30, 2022 | 3.03% |
| Jun 30, 2022 | 535.30% |
| Mar 31, 2022 | 5.00% |
| Dec 31, 2021 | 110.26% |
| Sep 30, 2021 | 19.35% |
| Jun 30, 2021 | -124.45% |